Trevarx Biomedical, Inc.

Philadelphia, PA · Founded 2016 · Medtech · Private

PET imaging tracer [18F]Fluorthanatrace for PARP expression quantification and PARPi drug engagement visualization in tumors

Claim this profile

Follows are private to you and power your alerts

Updated · trevarx.com

Sector
Medtech
Headquarters
Philadelphia, PA
Founded
2016
Latest Form D
$350K, Aug 2025
Total capital
$3.9M
Federal grants
$2.4M
3 awards · 2021–2024
Rank in peer group#61 of 112
Private capital raised
$1.5M
3 Form D · last Aug 2025
15 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

2019202020212022202320242025FEDERAL ↑EQUITY ↓Cumulative $3.9M$390K$1M$979K1st Form D$650K2nd Form D$500K3rd Form D$350K
2019202120232025FEDERAL ↑EQUITY ↓Cumulative $3.9M$390K$1M$979K1st Form D$650K2nd Form D$500K

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$350K
  • Federal grantHealth and Human S · Phase II · Optimizing Radiosynthetic Yield of [18F]FTT For Wide-Spread Distribution$979K
  • Federal grantHealth and Human S · Phase II · Optimizing Radiosynthetic Yield of [18F]FTT For Wide-Spread Distribution$1M
  • Private capital raisedForm D · SEC · 2nd filing$500K
  • Federal grantHealth and Human S · Phase I · Optimizing Radiosynthetic Yield of [18F]FTT For Wide-Spread Distribution$390K
  • Private capital raisedForm D · SEC · 1st filing$650K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 112 peers

Line = median

Medtech · Instrument

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Jean ChoResearcherExecutive Officer, DirectorLinked by $979K in grants as PI

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • Agenus Inc.Similar federal contract value in Medtech · null in contracts
  • MR-LINK, LLCSimilar federal contract value in Medtech · null in contracts
  • ENDOPROTECH, INC.Similar federal contract value in Medtech · null in contracts
  • Glauconix Inc.Similar federal contract value in Medtech · null in contracts
  • COLDSTEEL LASER, INCSimilar federal contract value in Medtech · null in contracts
  • KENTUCKY IMAGING TECHNOLOGIES, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .